Evidence supporting the use of: Oxytocin
For the health condition: Abuse and Trauma
Synopsis
Source of validity: Scientific
Rating (out of 5): 2
Oxytocin, a neuropeptide produced in the hypothalamus, is often referred to as the “bonding hormone” due to its established role in social behavior, trust, and emotional regulation. There is emerging scientific interest in its potential to support individuals who have experienced abuse and trauma, particularly in the context of post-traumatic stress disorder (PTSD) and difficulties with social engagement and trust. Several small-scale studies and pilot clinical trials have explored intranasal oxytocin administration as an adjunct to psychotherapy or as a standalone intervention. Some findings suggest that oxytocin may reduce anxiety, modulate fear responses, and enhance social bonding, which could be beneficial in the therapeutic process for trauma survivors. However, results are mixed, with some studies showing limited or no benefit, and a few indicating potential adverse effects such as increased emotional vulnerability in certain individuals. Systematic reviews conclude that while the theoretical rationale is compelling, robust clinical evidence remains limited and inconsistent. Current evidence does not support routine clinical use of oxytocin for abuse and trauma, but ongoing research may clarify its role. As such, oxytocin’s use in this context is supported by early-stage scientific investigation but lacks strong, replicated clinical validation.
Other health conditions supported by Oxytocin
Abuse and TraumaAddictions (drugs)
Anxiety
Anxiety Disorders
Autism
Depression
Emotional Sensitivity
Labor and Delivery
Mood Swings
Nursing
Post Traumatic Stress Disorder
Stress